Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Kidney (renal cell) cancer
Stage/Subtype:  stage I renal cell cancer
Trial Type:  Treatment
Results 1-11 of 11 for your search:
Start Over
Radiosurgery in Treating Patients with Stage I Kidney Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-235, NCI-2013-01825, NCT01890590
Capmatinib in Treating Patients with Papillary Kidney Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0037, NCI-2014-02464, 140037, 340263, 09-25-0099, P131324, NCT02019693
Stereotactic Body Radiation Therapy Compared to Radiofrequency Ablation in Treating Patients with Localized Kidney Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2013.069, NCI-2014-01216, 2013.069, HUM00076618, NCT02138578
Stereotactic Ablative Body Radiation Therapy in Treating Patients with Kidney Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: STU 122013-030, NCI-2014-02122, NCT02141919
Cabozantinib-S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients with Locally Advanced or Metastatic Kidney Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Any age
Trial IDs: S1500, NCI-2015-01707, NCT02761057
Cabozantinib-S-Malate in Treating Younger Patients with Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 2 to 30
Trial IDs: ADVL1622, NCI-2016-01258, NCT02867592
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Vaccine Therapy before Surgery in Treating Patients with Localized Kidney Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 250113, NCI-2014-01254, AGS-003-012, NCT02170389
Nivolumab in Treating Patients with HIgh-Risk Non-Metastatic Kidney Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9913, NCI-2015-01913, 16-195 A(1), NCT02595918
sEphB4-HSA before Surgery in Treating Patients with Bladder Cancer, Prostate Cancer, or Kidney Cancer
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 0S-15-6, NCI-2015-02236, NCT02767921
Enzalutamide before Surgery in Treating Patients with Kidney Cancer
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 081604, NCI-2016-01113, NCT02885649
Start Over